Showing results (131-140 of 170) with videos related to
Sort By:
Pageof 17
Frontiers in Medicine|May 22, 2020
Effects of Label Noise on Deep Learning-Based Skin Cancer ClassificationAchim Hekler, Jakob N Kather, Eva Krieghoff-Henning, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabAlexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.European Journal of Cancer (Oxford, England : 1990)|April 25, 2023
Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective AnalysisJuergen Hench, Daniela Mihic-Probst, Abbas Agaimy, et al.European Journal of Cancer (Oxford, England : 1990)|July 24, 2023
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) studyGeorg C Lodde, Jessica Hassel, Lena M Wulfken, et al.Journal of Medical Internet Research|July 13, 2021
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic ReviewJulia Höhn, Achim Hekler, Eva Krieghoff-Henning, et al.European Journal of Cancer (Oxford, England : 1990)|June 28, 2025
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinomaViola K DeTemple, Martin Kaatz, Eggert Stockfleth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III MelanomaGeorg C Lodde, Jessica C Hassel, Imke von Wasielewski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabBenjamin Weide, Alexander Martens, Jessica C Hassel, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysisGlenn Geidel, Sabrina Bänsch, Laura Adam, et al.European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
A benchmark for neural network robustness in skin cancer classificationRoman C Maron, Justin G Schlager, Sarah Haggenmüller, et al.Pageof 17